Cardiac
Issues in Congenital Central Hypoventilation Syndrome (CCHS)
(Summary as
it relates to Wyatt, 20/33 PHOX2B genotype/mutation)
·
Abstracts from 2008 study on 20/25, 20/26 and 20/27 PHOX2B genotype/mutation
http://www.cchsnetwork.org/images/stories/PDF/literature/CCHS_Cardiac_Issues.pdf
“Minimum heart rate
varied by genotype (w2 2df ¼ 6:89, P¼0.03),
with lowest values obtained for the subjects with the 20/27 genotype (genotype
20/25 vs. 20/27 comparison P¼0.02, 20/25 vs. 20/26: P¼0.07,
20/26 vs. 20/27: P¼0.2).”
“The longest r-r interval
was found to be independent of the baseline heart rate as well as the time of
day.”
“Though longest QTc
interval did not vary by genotype, all children with CCHS had at least one Holter
with a QTc interval above 450 msec, and the percent of QTc above 450 msec was
substantial considering the overall rarity of QTc greater than 440 msec in normal
children.”
“Though some children may
demonstrate staring spells or syncope at the time of the transient asystole,
most subjects are asymptomatic. This underlying propensity for prolonged r-r
interval may increase the vulnerability of the child with CCHS when exposed to pharmacologic
agents or anesthesia.”
“The reticence to implant
a cardiac pacemaker may be the result of uncertainty as to the clinical significance
of prolonged r-r intervals in the seemingly asymptomatic subject, particularly
if subsequent r-r intervals are shorter than 3 sec. Because the impact of prolonged
sinus pauses on long term neurodevelopment is unknown, and because childhood is
such a critical period for neurocognitive development coupled with the overriding
risk for sudden death, recommendation for implantation of a cardiac pacemaker
in the child with CCHS and r-r intervals of 3 sec or longer seems to be the most
conservative recommendation.”
·
Abstracts from the 2010 American Thoracic Society,
Clinical Policy Statement: Congenital Central Hypoventilation Syndrome http://www.cchsnetwork.org/images/stories/PDF/literature/CCHS-ATS.pdf
“Cardiac rhythm
abnormalities, including decreased beat-to-beat heart rate variability, reduced
respiratory sinus arrhythmia, and transient abrupt asystoles, have been
described (9, 101, 102). Seventy-two–hour Holter monitoring performed annually
may determine aberrant cardiac rhythms, sinus pauses that will necessitate
bipolar cardiac pacemaker implantation (103), and the frequency of shorter
pauses (i.e., less than 3 s) that may have physiologic and neurocognitive
impact.”
·
Statement on Cardiac Pacing in CCHS written by Dr. Tom Keens
http://www.cchsnetwork.org/images/stories/PDF/literature/cchs%20cardiac%20pacing%20keens%203_13.pdf